Boxed Warning For Antipsychotics First Public Use Of FDA Labeling Authority

FDA put its new labeling authority under the FDA Amendments Act on public display June 16 by directing makers of conventional antipsychotics to add to their drugs' prescribing information a boxed warning about use in elderly patients with dementia